Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

MiNK Therapeutics, Inc. - Common Stock (NQ: INKT )

7.980 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MiNK Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
From MiNK Therapeutics
Via GlobeNewswire
MiNK Presents Clinical Data on Allogeneic iNKT Cells (agenT-797) in Severe Respiratory Distress at the American Thoracic Society International Conference
From MiNK Therapeutics
Via GlobeNewswire
MiNK's Novel FAP-CAR-iNKT Presented at ASGCT
From MiNK Therapeutics
Via GlobeNewswire
The Latest Analyst Ratings for MiNK Therapeutics
Via Benzinga
Recap: MiNK Therapeutics Q1 Earnings
Via Benzinga
Over $1M Bet On This Basic Materials Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed slightly lower on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny... 
Via Benzinga
MiNK Therapeutics Reports Corporate Update and First Quarter 2023 Financial Results
From MiNK Therapeutics
Via GlobeNewswire
First Foundation And 2 Other Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed lower on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Preview: MiNK Therapeutics's Earnings
Via Benzinga
MiNK Therapeutics to Report First Quarter 2023 Corporate Update and Financial Results
From MiNK Therapeutics
Via GlobeNewswire
MiNK Therapeutics Announces Clinical Data of Allogeneic iNKT Cells (agenT-797) in Solid Tumor Cancers at the AACR Annual Meeting
From MiNK Therapeutics
Via GlobeNewswire
Agenus Announces Dividend of 5 Million Shares of MiNK Therapeutics
From Agenus Inc.
Via Business Wire
MiNK Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
From MiNK Therapeutics
Via GlobeNewswire
Earnings Scheduled For March 21, 2023
Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.20 per share on revenue of $41.75 million. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
MiNK Therapeutics to Present Updated Clinical Data of allo-iNKT Cell Therapy in Solid Tumors at AACR Annual Meeting
From MiNK Therapeutics
Via GlobeNewswire
MiNK Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results
From MiNK Therapeutics
Via GlobeNewswire
MiNK Therapeutics to Participate in HC Wainwright Cell Therapy Virtual Conference
From MiNK Therapeutics
Via GlobeNewswire
MiNK Therapeutics to Participate in B. Riley Securities Oncology Conference
From MiNK Therapeutics
Via GlobeNewswire
Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive... 
Via Benzinga
MiNK Therapeutics to Participate in Evercore ISI HealthCONx Conference
From MiNK Therapeutics
Via GlobeNewswire
Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday. 
Via Benzinga
MiNK Presents Clinical Data at SITC 2022 Showcasing iNKT Cell Therapy Pipeline
From MiNK Therapeutics
Via GlobeNewswire
MiNK Therapeutics Reports Corporate Update and Third Quarter 2022 Financial Results
From MiNK Therapeutics
Via GlobeNewswire
MiNK Therapeutics to Report Third Quarter 2022 Financial Results and Business Update
Conference Call on Thursday, November 3rd, 2022, at 8:30 a.m. ET 
From MiNK Therapeutics
Via GlobeNewswire
MiNK Therapeutics to Host R&D Event November 10, 2022
From MiNK Therapeutics
Via GlobeNewswire
MiNK Selected for Five Presentations at Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
From MiNK Therapeutics
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
  
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.